Susan A. Knudson
2019 - Pfenex
In 2019, Susan A. Knudson earned a total compensation of $649.2K as Former Chief Financial Officer at Pfenex, a 16% decrease compared to previous year.
Compensation breakdown
Non-Equity Incentive Plan | $154,350 |
---|---|
Option Awards | $152,889 |
Salary | $342,000 |
Total | $649,239 |
Knudson received $342K in salary, accounting for 53% of the total pay in 2019.
Knudson also received $154.4K in non-equity incentive plan and $152.9K in option awards.
Rankings
In 2019, Susan A. Knudson's compensation ranked 10,968th out of 13,971 executives tracked by ExecPay. In other words, Knudson earned more than 21.5% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 10,968 out of 13,971 | 22nd |
Division Manufacturing | 4,438 out of 5,701 | 22nd |
Major group Chemicals And Allied Products | 1,740 out of 2,200 | 21st |
Industry group Drugs | 1,494 out of 1,886 | 21st |
Industry Pharmaceutical Preparations | 1,105 out of 1,398 | 21st |
Source: SEC filing on April 1, 2020.
Knudson's colleagues
We found four more compensation records of executives who worked with Susan A. Knudson at Pfenex in 2019.
News
Conatus Pharmaceuticals CFO Susan Knudson's 2022 pay jumps 26% to $681K
May 1, 2023
Conatus Pharmaceuticals CEO Steven Mento's 2020 pay slips 5% to $1.3M
April 15, 2021
Pfenex CEO Evert Schimmelpennink's 2019 pay rises 11% to $1.8M
April 1, 2020
Neothetics CEO Saundra Pelletier's 2018 pay jumps 401% to $8.3M
April 24, 2019
Pfenex CEO Evert Schimmelpennink's 2018 pay jumps 47% to $1.6M
April 4, 2019